Parkinsonism associated with calcium channel blockers: a prospective follow-up study.

Abstract

Parkinsonism is a well-known side effect of some calcium channel blockers (CCB). Its long-term evolution, however, is unknown. To clarify this issue, we performed a prospective follow-up study involving 32 patients diagnosed with CCB-induced parkinsonism. After the baseline examination, the CCB were discontinued and serial evaluations were carried out… (More)

Topics

Cite this paper

@article{GarcaRuiz1992ParkinsonismAW, title={Parkinsonism associated with calcium channel blockers: a prospective follow-up study.}, author={Pedro Jos{\'e} Garc{\'i}a-Ruiz and Justo Garc{\'i}a de Y{\'e}benes and F{\'e}lix Javier Jim{\'e}nez-Jim{\'e}nez and Antonia V{\'a}zquez and D Garc{\'i}a Urra and Bryan Morales}, journal={Clinical neuropharmacology}, year={1992}, volume={15 1}, pages={19-26} }